Oral sumatriptan and almotriptan--delimiting the MAOI effect.

Headache 20120501

Italian guidelines for primary headaches: 2012 revised version.

The journal of headache and pain 20120501

Efficacy of frovatriptan versus other triptans in the acute treatment of menstrual migraine: pooled analysis of three double-blind, randomized, crossover, multicenter studies.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20120501

Pharmacokinetics and tolerability of rizatriptan in pediatric migraineurs in a randomized study.

Headache 20120401

Migraine in women: the role of hormones and their impact on vascular diseases.

The journal of headache and pain 20120401

LC-ESI-MS/MS determination of in vivo metabolites of almotriptan in rat plasma, urine and feces: application to pharmacokinetics.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20120401

Will (or can) people pay for headache care in a poor country?

The journal of headache and pain 20120101

Two chromatographic methods for the determination of some antimigraine drugs.

Analytical chemistry insights 20120101

Method development and validation of almotriptan in human plasma by HPLC tandem mass spectrometry: application to pharmacokinetic study.

Scientia pharmaceutica 20120101

The impact of allodynia on the efficacy of almotriptan when given early in migraine: data from the 'Act when mild' study.

The International journal of neuroscience 20111201

Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptan.

The journal of headache and pain 20111201

Suggested randomised, controlled trial with frovatriptan.

The journal of headache and pain 20111201

Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

PLoS computational biology 20111201

Are menstrual and nonmenstrual migraine attacks different?

Current pain and headache reports 20111001

Efficacy and tolerability of almotriptan in menstrual migraine: a comment.

Expert opinion on pharmacotherapy 20111001

Effect of iontophoresis on in vitro transdermal absorption of almotriptan.

International journal of pharmaceutics 20110915

Almotriptan for menstrually related migraine.

Expert opinion on pharmacotherapy 20110801

Optimal balance of efficacy and tolerability of oral triptans and telcagepant: a review and a clinical comment.

The journal of headache and pain 20110601

A double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraine.

The journal of headache and pain 20110601

When to use frovatriptan in migraine?

The journal of headache and pain 20110601

Triptan overuse in the Dutch general population: a nationwide pharmaco-epidemiology database analysis in 6.7 million people.

Cephalalgia : an international journal of headache 20110601

Frovatriptan versus other triptans in the acute treatment of migraine: pooled analysis of three double-blind, randomized, cross-over, multicenter, Italian studies.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20110501

Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, multicenter, Italian, comparative study versus zolmitriptan.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20110501

Improved patient satisfaction and pain evolution with almotriptan in migraine: a primary care study.

Current medical research and opinion 20110301

Triptans other than sumatriptan in child and adolescent migraine: literature review.

Expert review of neurotherapeutics 20110301

Why pharmacokinetic differences among oral triptans have little clinical importance: a comment.

The journal of headache and pain 20110201

Acute migraine therapy: new drugs and new approaches.

Current treatment options in neurology 20110201

Overview of diagnosis and management of paediatric headache. Part II: therapeutic management.

The journal of headache and pain 20110201

Almotriptan 12.5 mg in menstrually related migraine: a randomized, double-blind, placebo-controlled study.

Cephalalgia : an international journal of headache 20110101

Excellent tolerability but relatively low initial clinical efficacy of telcagepant in migraine.

Headache 20110101

Randomised controlled trial of food elimination diet based on IgG antibodies for the prevention of migraine like headaches.

Nutrition journal 20110101

The use of triptans for pediatric migraines.

Paediatric drugs 20101201

Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Bioorganic & medicinal chemistry letters 20101101

Almotriptan for the acute treatment of adolescent migraine.

Expert opinion on pharmacotherapy 20101001

Almotriptan: a review of 10 years' clinical experience.

Expert review of neurotherapeutics 20101001

Almotriptan efficacy in migraine with allodynia: a rebuttal to Burstein and Jakubowski's critique of Schoenen et al.

Cephalalgia : an international journal of headache 20100901

Influence of trigger factors on the efficacy of almotriptan as early intervention for the treatment of acute migraine in a primary care setting: the START study.

Expert review of neurotherapeutics 20100901

Triptans for the management of migraine.

Drugs 20100820

Early responses in randomized clinical trials of triptans in acute migraine treatment. Are they clinically relevant? A comment.

Headache 20100701

Evolution of migraine-associated symptoms in menstrually related migraine following symptomatic treatment with almotriptan.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20100601

Efficacy of almotriptan in early intervention for treatment of acute migraine in a primary care setting: the START study.

International journal of clinical practice 20100601

Long-term, open-label safety study of oral almotriptan 12.5 mg for the acute treatment of migraine in adolescents.

Headache 20100501

Drug dependence associated with triptans and ergot derivatives: a case/non-case study.

European journal of clinical pharmacology 20100401

Acute management of migraine.

The Journal of the Association of Physicians of India 20100401

Almotriptan for the treatment of acute migraine: a review of early intervention trials.

Expert review of neurotherapeutics 20100301

Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice.

Annals of the rheumatic diseases 20100201

Development and validation of the Treatment Related Impact Measure of Weight (TRIM-Weight).

Health and quality of life outcomes 20100101

Pregabalin in fibromyalgia--responder analysis from individual patient data.

BMC musculoskeletal disorders 20100101

Effect of preventive (beta blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: randomised controlled trial.

BMJ (Clinical research ed.) 20100101

Development and Validation of HPTLC Method for the Estimation of Almotriptan Malate in Tablet Dosage Form.

Indian journal of pharmaceutical sciences 20100101

[Acute migraine: a treatment reserved for adults now recommended for adolescents].

Perspective infirmiere : revue officielle de l'Ordre des infirmieres et infirmiers du Quebec 20100101

Early treatment of acute migraine: new evidence of benefits.

Cephalalgia : an international journal of headache 20091201

Almotriptan efficacy in migraine with allodynia: a critique of Schoenen et al.

Cephalalgia : an international journal of headache 20091001

Variation in almotriptan effectiveness according to different prophylactic treatments.

Headache 20091001

5-Hydroxytryptamine Receptor Subtypes and their Modulators with Therapeutic Potentials.

Journal of clinical medicine research 20090601

Migraine treatment with rizatriptan and almotriptan: a crossover study.

Headache 20090501

[Almotriptan vs. ergotamine plus caffeine for acute migraine treatment. A cost-efficacy analysis].

Neurologia (Barcelona, Spain) 20090401

Allodynia-associated symptoms, pain intensity and time to treatment: predicting treatment response in acute migraine intervention.

Headache 20090301

Almotriptan efficacy in migraine with developing allodynia is as high as the efficacy in migraine without allodynia--but is it the same in migraine with established allodynia?

Headache 20090301

Individual triptan selection in migraine attack therapy.

Recent patents on CNS drug discovery 20090101

Validation of an abbreviated Treatment Satisfaction Questionnaire for Medication (TSQM-9) among patients on antihypertensive medications.

Health and quality of life outcomes 20090101

Rizatriptan for the acute treatment of migraine: Consistency, preference, satisfaction, and quality of life.

Patient preference and adherence 20090101

Recent advances in the pharmacological management of migraine.

F1000 medicine reports 20090101

Current migraine management - patient acceptability and future approaches.

Neuropsychiatric disease and treatment 20081201

Prophylaxis of migraine: general principles and patient acceptance.

Neuropsychiatric disease and treatment 20081201

Efficacy and tolerability of almotriptan in adolescents: a randomized, double-blind, placebo-controlled trial.

Headache 20081001

Almotriptan and its combination with aceclofenac for migraine attacks: a study of efficacy and the influence of auto-evaluated brush allodynia.

Cephalalgia : an international journal of headache 20081001

Optimizing prophylactic treatment of migraine: Subtypes and patient matching.

Therapeutics and clinical risk management 20081001

Seizure after use of almotriptan.

Clinical neurology and neurosurgery 20080901

Almotriptan in triptan-naïve patients: new evidence of benefits.

Cephalalgia : an international journal of headache 20080901

Pathways to the best fit of triptans for migraine patients.

Cephalalgia : an international journal of headache 20080901

The 'Act when Mild' (AwM) study: a step forward in our understanding of early treatment in acute migraine.

Cephalalgia : an international journal of headache 20080901

Applying the benefits of the AwM study in the clinic.

Cephalalgia : an international journal of headache 20080901

Meeting patient expectations in migraine treatment: what are the key endpoints?

The journal of headache and pain 20080801

Acute migraine therapy: recent evidence from randomized comparative trials.

Current opinion in neurology 20080601

Indolealkylamines: biotransformations and potential drug-drug interactions.

The AAPS journal 20080601

Early vs. non-early intervention in acute migraine-'Act when Mild (AwM)'. A double-blind, placebo-controlled trial of almotriptan.

Cephalalgia : an international journal of headache 20080401

Pharmacoeconomic benefits of almotriptan in the acute treatment of migraine.

Expert review of pharmacoeconomics & outcomes research 20080401

A validated reversed phase HPLC method for the determination of process-related impurities in almotriptan malate API.

Journal of pharmaceutical and biomedical analysis 20080313

Migraine-like headache in intracranial haemorrhage is alleviated by sumatriptan and almotriptan.

Cephalalgia : an international journal of headache 20080301

Effect of early intervention with almotriptan vs placebo on migraine-associated functional disability: results from the AEGIS Trial.

Headache 20080301

Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine.

Headache 20080201

Triptans in pregnancy.

Therapeutic drug monitoring 20080201

Characteristics of migraine attacks and responses to almotriptan treatment: a comparison of menstrually related and nonmenstrually related migraines.

Headache 20080201

Review of frovatriptan in the treatment of migraine.

Neuropsychiatric disease and treatment 20080201

Almotriptan, an antimigraine agent, and its malate salt.

Acta crystallographica. Section C, Crystal structure communications 20080101

Almotriptan: meeting today's needs in acute migraine treatment.

Expert review of neurotherapeutics 20071201

Almotriptan in the treatment of migraine.

Neuropsychiatric disease and treatment 20071201

Use of almotriptan in triptan-experienced and triptan-naïve patients.

Current medical research and opinion 20071001

Triptans in the treatment of migraine: drug selection by means of the SOJA method.

Expert opinion on pharmacotherapy 20071001

Meta-analysis examining the efficacy and safety of almotriptan in the acute treatment of migraine.

Headache 20070901

Efficacy of dosing and re-dosing of two oral fixed combinations of indomethacin, prochlorperazine and caffeine compared with oral sumatriptan in the acute treatment of multiple migraine attacks: a double-blind, double-dummy, randomised, parallel group, multicentre study.

International journal of clinical practice 20070801

Economic analysis of triptan therapy for acute migraine: a Medicaid perspective.

Pharmacotherapy 20070801

Times to pain relief and pain freedom with rizatriptan 10 mg and other oral triptans.

International journal of clinical practice 20070701

Acute migraine: Current treatment and emerging therapies.

Therapeutics and clinical risk management 20070601

Do 5HT1B/1D receptor agonists have an effect on mood and anxiety disorders?

Cephalalgia : an international journal of headache 20070501

Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS).

Headache 20070401

Crossover, double-blind clinical trial comparing almotriptan and ergotamine plus caffeine for acute migraine therapy.

European journal of neurology 20070301

Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).

Headache 20070201

Patient preference in migraine therapy. A randomized, open-label, crossover clinical trial of acute treatment of migraine with oral almotriptan and rizatriptan.

Journal of neurology 20070201

Almotriptan and zolmitriptan in the acute treatment of migraine.

Acta neurologica Scandinavica 20070101

Use of the sustained pain-free plus no adverse events endpoint in clinical trials of triptans in acute migraine.

CNS drugs 20070101

Examining correlates of treatment satisfaction for injectable insulin in type 2 diabetes: lessons learned from a clinical trial comparing biphasic and basal analogues.

Health and quality of life outcomes 20070101

A pharmacoeconomic evaluation of oral triptans in the treatment of migraine in Italy.

Minerva medica 20061201

Gateways to clinical trials.

Methods and findings in experimental and clinical pharmacology 20061101

Disposition and metabolism of almotriptan in rats, dogs and monkeys.

Xenobiotica; the fate of foreign compounds in biological systems 20060901

Ethanol does not significantly affect the bioavailability of almotriptan: an open, randomized, crossover, single-dose, phase I clinical trial in healthy volunteers.

International journal of clinical pharmacology and therapeutics 20060901

Rizatriptan in the treatment of migraine.

Neuropsychiatric disease and treatment 20060901

Efficacy and tolerability of almotriptan versus zolmitriptan for the acute treatment of menstrual migraine.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20060501

Efficacy, speed of action and tolerability of almotriptan in the acute treatment of migraine: pooled individual patient data from four randomized, double-blind, placebo-controlled clinical trials.

Cephalalgia : an international journal of headache 20060401

Effect of food intake on the bioavailability of almotriptan, an antimigraine compound, in healthy volunteers: an open, randomized, crossover, single-dose clinical trial.

International journal of clinical pharmacology and therapeutics 20060401

Almotriptan in the acute treatment of migraine in patients 11-17 years old: an open-label pilot study of efficacy and safety.

The journal of headache and pain 20060401

[Economic evaluation of acute migraine attack treatment with triptans in Spain].

Neurologia (Barcelona, Spain) 20060301

Infrequent or non-response to oral sumatriptan does not predict response to other triptans--review of four trials.

Cephalalgia : an international journal of headache 20060201

Value of postmarketing surveillance studies in achieving a complete picture of antimigraine agents: using almotriptan as an example.

The journal of headache and pain 20060201

Evaluation of efficacy, tolerability, and treatment satisfaction with almotriptan in 3 consecutive migraine attacks. The migraine--satisfaction with treatment: reality with Almogran study.

European neurology 20060101

Eletriptan: a review of its use in the acute treatment of migraine.

Drugs 20060101

[Clinical use of triptans in the management of migraine].

CNS drugs 20060101

Using patient-centered endpoints to determine the cost-effectiveness of triptans for acute migraine therapy.

American journal of therapeutics 20060101

Spotlight on eletriptan in migraine.

CNS drugs 20060101

A comparative study on the cost of new antibiotics and drugs of other therapeutic categories.

PloS one 20060101

Focus on trial endpoints of clinical relevance and the use of almotriptan for the acute treatment of migraine.

International journal of clinical practice 20051101

Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg.

Current medical research and opinion 20051001

Gateways to clinical trials.

Methods and findings in experimental and clinical pharmacology 20051001

The use of multiattribute decision models in evaluating triptan treatment options in migraine.

Journal of neurology 20050901

Multiple attack study on the available triptans in Italy versus placebo.

European journal of neurology 20050701

Consistent efficacy, tolerability, and high levels of satisfaction with almotriptan 12.5 mg when used to treat multiple migraine attacks in routine clinical practice.

Headache 20050601

Prediction of genotoxicity of chemical compounds by statistical learning methods.

Chemical research in toxicology 20050601

Anti-migraine action of triptans is preceded by transient aggravation of headache caused by activation of meningeal nociceptors.

Pain 20050501

Effects of symptomatic treatments on cutaneous hyperalgesia and laser evoked potentials during migraine attack.

Cephalalgia : an international journal of headache 20050501

Early triptan intervention in migraine: an overview.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20050501

[Economic evaluation of acute migraine attack treatment with triptans in Spain].

Neurologia (Barcelona, Spain) 20050401

How treatment priorities influence triptan preferences in clinical practice: perspectives of migraine sufferers, neurologists, and primary care physicians.

Current medical research and opinion 20050301

Triptan nonresponder studies: implications for clinical practice.

Headache 20050201

Correlation between lipophilicity and triptan outcomes.

Headache 20050101

[Tolerance to almotriptan and its effectiveness in primary care].

Atencion primaria 20050101

Clinical pharmacokinetics of almotriptan, a serotonin 5-HT(1B/1D) receptor agonist for the treatment of migraine.

Clinical pharmacokinetics 20050101

Oral serotonin receptor agonists: a review of their cost effectiveness in migraine.

PharmacoEconomics 20050101

Defining response in migraine: which endpoints are important?

European neurology 20050101

Efficacy and tolerability of almotriptan in controlled clinical trials.

European neurology 20050101

Efficacy and tolerability of almotriptan in postmarketing surveillance studies.

European neurology 20050101

Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.

European neurology 20050101

Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.

Headache 20050101

[Management costs of chest and CNS-related adverse events associated with the treatment of acute migraine attacks with oral triptans].

Neurologia (Barcelona, Spain) 20050101

Rizatriptan: a pharmacoeconomic review of its use in the acute treatment of migraine.

PharmacoEconomics 20050101

Pharmacokinetics and safety of oral almotriptan in healthy male volunteers.

Biopharmaceutics & drug disposition 20041001

Evaluating triptan usage: a rebuttal.

Headache 20041001

TRIPSTAR: prioritizing oral triptan treatment attributes in migraine management.

Acta neurologica Scandinavica 20040901

Priorities for triptan treatment attributes and the implications for selecting an oral triptan for acute migraine: a study of US primary care physicians (the TRIPSTAR Project).

Clinical therapeutics 20040901

[Meta-analysis of triptan treatment in migraine].

No to shinkei = Brain and nerve 20040901

Meta-analysis of oral triptans.

Cephalalgia : an international journal of headache 20040801

Involvement of 5-HT1B receptors in triptan-induced contractile responses in guinea-pig isolated iliac artery.

Naunyn-Schmiedeberg's archives of pharmacology 20040701

Triptans and CNS side-effects: pharmacokinetic and metabolic mechanisms.

Cephalalgia : an international journal of headache 20040601

[Almotriptan. One more triptan for migraines].

Revue de l'infirmiere 20040601

Oral almotriptan: practical uses in the acute treatment of migraine.

Expert review of neurotherapeutics 20040501

A comparison of the pharmacokinetics and tolerability of the anti-migraine compound almotriptan in healthy adolescents and adults.

Cephalalgia : an international journal of headache 20040401

Triptans and chest symptoms: the role of pulmonary vasoconstriction.

Cephalalgia : an international journal of headache 20040401

Almotriptan improves response rates when treatment is within 1 hour of migraine onset.

Headache 20040401

Cost considerations of acute migraine treatment.

Headache 20040301

Evaluating triptan usage.

Headache 20040201

Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease.

Health and quality of life outcomes 20040101

Gateways to clinical trials.

Methods and findings in experimental and clinical pharmacology 20040101

Patterns of use of triptans and reasons for switching them in a tertiary care migraine population.

Headache 20040101

A comparison of the cost-effectiveness of almotriptan and sumatriptan in the treatment of acute migraine using a composite efficacy/tolerability end point.

Journal of managed care pharmacy : JMCP 20040101

Migraine pathophysiology and its clinical implications.

Cephalalgia : an international journal of headache 20040101

What do patients want from acute migraine treatment?

Cephalalgia : an international journal of headache 20040101

Clinical profile and practice experience of almotriptan.

Cephalalgia : an international journal of headache 20040101

Clinical benefits of early triptan therapy for migraine.

Cephalalgia : an international journal of headache 20040101

Gateways to clinical trials.

Methods and findings in experimental and clinical pharmacology 20031201

Cost-effectiveness of almotriptan and rizatriptan in the treatment of acute migraine.

Clinical therapeutics 20031101

A review of the clinical efficacy and tolerability of almotriptan in acute migraine.

Expert opinion on pharmacotherapy 20030701

Identification of the human liver enzymes involved in the metabolism of the antimigraine agent almotriptan.

Drug metabolism and disposition: the biological fate of chemicals 20030401

Interaction between ketoconazole and almotriptan in healthy volunteers.

Journal of clinical pharmacology 20030401

A case of carotidynia with response to almotriptan.

Cephalalgia : an international journal of headache 20030301

Gateways to clinical trials. March 2003.

Methods and findings in experimental and clinical pharmacology 20030301

Safety profile of the triptans.

Expert opinion on drug safety 20030301

A review of the effects of almotriptan and other triptans on clinical trial outcomes that are meaningful to patients with migraine.

Clinical therapeutics 20030201

[Almotriptan in the treatment of migraine attacks in clinical practice: results of the TEA 2000 observational study].

Neurologia (Barcelona, Spain) 20030101

Almotriptan versus rizatriptan in patients with migraine in Spain.

Headache 20030101

Migraine: diagnosis and management.

Internal medicine journal 20030101

Newer formulations of the triptans: advances in migraine management.

Drugs 20030101

Meta-analysis of oral triptan therapy for migraine: number needed to treat and relative cost to achieve relief within 2 hours.

Journal of managed care pharmacy : JMCP 20030101

Early intervention with almotriptan improves sustained pain-free response in acute migraine.

Headache 20030101

Almotriptan: an effective and well-tolerated treatment for migraine pain.

Drugs of today (Barcelona, Spain : 1998) 20030101

Current perspectives on effective migraine treatments: are small clinical differences important for patients?

Drugs of today (Barcelona, Spain : 1998) 20030101

Absolute bioavailability, pharmacokinetics, and urinary excretion of the novel antimigraine agent almotriptan in healthy male volunteers.

Journal of clinical pharmacology 20021201

Gateways to clinical trials.

Methods and findings in experimental and clinical pharmacology 20021201

Efficacy and safety of almotriptan malate for migraine.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20021115

New medications show promise for migraine sufferers.

Dentistry today 20021001

Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials.

Cephalalgia : an international journal of headache 20021001

Mechanisms of action of the 5-HT1B/1D receptor agonists.

Archives of neurology 20020701

Almotriptan is an effective and well-tolerated treatment for migraine pain: results of a randomized, double-blind, placebo-controlled clinical trial.

Cephalalgia : an international journal of headache 20020701

New drugs 2002, part III.

Nursing 20020701

Gateways to Clinical Trials. June 2002.

Methods and findings in experimental and clinical pharmacology 20020601

Use of rescue medication in trials of almotriptan versus placebo in the treatment of acute migraine.

Clinical therapeutics 20020401

Triptan medications to treat acute migraine.

Lancet (London, England) 20020330

Triptan medications to treat acute migraine.

Lancet (London, England) 20020330

Triptan medications to treat acute migraine.

Lancet (London, England) 20020330

Cardiovascular effect of almotriptan in treated hypertensive patients.

Clinical pharmacology and therapeutics 20020301

Almotriptan (Axert) and frovatriptan (Frova) for migrane.

The Medical letter on drugs and therapeutics 20020218

Cost savings in migraine associated with less chest pain on new triptan therapy.